Significant differences in incubation times in sheep infected with bovine spongiform encephalopathy result from variation at codon 141 in the PRNP gene
INTRODUCTION
Bovine spongiform encephalopathy (BSE) is a member of a group of fatal neurodegenerative diseases called transmissible spongiform encephalopathies (TSEs). Natural hosts of infection for the BSE agent are cattle and humans, but sheep can also be infected experimentally. Other examples of TSEs in animals are classical and atypical scrapie in sheep and goats and chronic wasting disease (CWD) in deer. It is widely believed that TSEs are caused by the misfolding of a host-expressed glycoprotein, called the prion protein (PrP C ). The pathological form of PrP manifest in diseased individuals is termed PrP Sc . Characteristic hallmarks of TSE disease include vacuolation in neural tissues and deposition of PrP Sc in brain and lymphoid tissue. Typically, the time between infection and the demonstration of clinical signs and ultimately death of an affected individual is long, in many cases years.
The prion protein is encoded by the PRNP gene, which in sheep is highly polymorphic (Baylis & Goldmann, 2004; Goldmann, 2008) . Common polymorphisms occur at positions 136, 154 and 171 and are responsible for encoding the amino acids alanine/valine (A/V), arginine/histidine (R/H) and glutamine/arginine/histidine (Q/R/H), respectively. The strain of the infecting agent and the route of infection, in combination with the amino acid expressed at these codons, modulate both the relative susceptibility to TSE infection and associated incubation periods. For example, the V 136 R 154 Q 171 allele (VRQ) is associated with a higher susceptibility to classical scrapie, compared with the ARR allele that is associated with increased resistance and lengthened incubation periods. Similarly, the ARQ allele is associated with susceptibility to experimental BSE infection in sheep compared with the ovine VRQ and ARR alleles. Additional PRNP coding region polymorphisms have been identified, though often they occur at low frequencies, which make it difficult to assess their association with TSE susceptibility. Nonetheless, polymorphisms such as M112T (Laegreid et al., 2008; Saunders et al., 2009) , P168L and N176K (Vaccari et al., 2007 (Vaccari et al., , 2009 ) all appear to be associated with protection against BSE or classical scrapie infection. In contrast, when phenylalanine (F) is substituted for the wild-type amino acid leucine (L) at codon 141 of ovine PRNP (Bossers et al., 1996) this change is associated with an increased susceptibility to atypical scrapie (Moum et al., 2005 
RESULTS AND DISCUSSION
Of the 39 sheep challenged with BSE brain homogenate, four were confirmed as negative for BSE infection at the time of euthanasia using both immunohistochemistry and Western blotting . Of the other 35 BSE-infected sheep, 32 were confirmed as having BSE and reached the clinical phase of disease with incubation periods ranging from 534 to 1593 days and a mean incubation period of 939±316.1 days (±SD). The remaining three sheep infected with BSE are alive and classed as survivors, though the pathological status of these animals is at present unknown. None of the negative controls developed disease. Although all sheep were of the ARQ/ ARQ genotype, the wide range of incubation times seen in the confirmed BSE cases prompted us to consider whether this could be explained by additional genetic effects in the PRNP gene. Further analysis of this gene revealed variation in the amino acid encoded at position 141 (L to F substitution). Sheep were grouped accordingly to whether they were LL 141 , FF 141 or LF 141 as shown in Table 1 . Fig. 1(a) shows a graphical representation of incubation periods for all BSE-infected sheep after subdividing them by codon 141 genotype. The median incubation periods of the cases that succumbed to BSE were 603 days post-inoculation (p.i.) for LL 141 sheep (n511), 840 days p.i. for FF 141 sheep (n58) and 1231 days p.i. for LF 141 sheep (n513). Standard Kaplan-Meier analysis of differences in incubation and survival times between the sheep in each genotype was carried out. This revealed highly significant differences in median incubation times in BSE-infected sheep between all three genotype subgroups (x 2 542.3, P,0.001, Fig. 1b ). In the same analyses, the four sheep that were culled but confirmed BSE negative were censored and the three sheep that are still alive were right-censored.
To investigate whether incubation period differences correlate with variations in PrP levels, we analysed homogenates, from the medulla, by Western blotting. Fig. 2(a) shows a representative immunoblot of PrP protein profiles in these homogenates, prepared from BSE-infected sheep, following detergent extraction and treatment either without (lanes 1-6, equating to total PrP protein) or with proteinase K (PK, 50 mg ml 21 ), respectively (lanes 7-12, equating to PK-resistant PrP Sc ). For each genotype subgroup, results from two animals are shown. The protein profile shown in lanes 7-12 confirms BSE infection by the presence of PKresistant PrP
Sc . The immunoblot of the same samples, though not treated with PK (in lanes 1-6) were also probed with an anti-tubulin antibody as a loading control (Fig.  2b ). Densitometric analysis (Fig. 3 ) identified no statistically significant differences (P.0.05, Tables 2 and 3) between genotype groups neither in terms of total PrP nor in disease-associated PrP Sc deposited in the medulla of the brain at the clinical end-point in BSE-infected sheep (Fig.  2a) . Thus, the increased incubation times in FF 141 and LF 141 sheep relative to LL 141 sheep could be caused by either delayed routeing of infection from the gut to the central nervous system or through a direct effect of the amino acid change on the ability of PrP C to misfold.
The importance of amino acid substitutions in the PrP protein for directing susceptibility to TSEs has long been recognized (Andréoletti et al., 2006; Foster et al., 2001; Goldmann et al., 2006; Houston et al., 2003) . Polymorphisms in the PRNP gene modulate not only susceptibility to prion disease but also alter incubation times and may account for some of the differences in pathology typically observed in affected individuals (Barron et al., 2005) . In sheep, the A136V mutation is associated with increased susceptibility to sheep scrapie, whereas Q171R is associated with resistance (Goldmann et al., 1991 (Goldmann et al., , 1994 Hunter et al., 1993) . Indeed, genetic variation in the PRNP gene and the associated outcomes in relation to disease resistance were used to devise the National Scrapie Plan for the control and eradication of classical scrapie within UK and European flocks (Dawson et al., 1998; Detwiler & Baylis, 2003) . Following the emergence of atypical scrapie (Benestad et al., 2003) and its association to the L141F polymorphism (Benestad et al., 2003; Moum et al., 2005) it became apparent that predictions regarding TSE susceptibility may have to be widened. Until now, a significant association with (Manson et al., 1994) since Western blotting in uninfected control sheep ( Fig. 2c and d lanes 13-15, respectively) has shown that the expression of PrP C in the three codon 141 genotypes is similar, although we were unable to perform statistical analysis due to the limited number of animals for study (Table 3) . It is conceivable, therefore, that the increased incubation periods in F 141 carriers may result from processes involving formation of PrP Sc . It is likely that the amino acid change has a direct effect on the ability of PrP C to convert to PrP Sc during disease, since it has been shown that PrP C containing phenylalanine at codon 141 converts less efficiently to PrP Sc when compared with the wild-type (L 141 ) counterpart in an in vitroconversion assay seeded with classical scrapie isolate (Bossers et al., 2000) . Whilst the infectious agent used in the in vitro study was scrapie rather than BSE, other work has shown that cell-free conversion assays replicate the effect of amino acid substitutions across multiple TSE strains. Hence, it is reasonable to suggest that such an experiment seeded with BSE would also show differential conversion of L 141 and F 141 proteins (Kirby et al., 2006) .
Assuming that the cattle BSE inoculum is trafficked across the intestinal epithelium equally in each genotype of sheep, differential conversion of the two proteins in our experimental model could occur at one of two subsequent phases of disease, as shown schematically in Fig. 4 . Firstly, the exogenous cattle PrP Sc converts endogenous ovine PrP C to ovPrP Sc and this initial cross-species conversion process Sc converts more ovPrP C to ovPrP Sc -a homologousconversion process. Based on these steps, several scenarios have been modelled, assuming different conversion efficiencies in both the cross-species and homologous-conversion reactions (Fig. 5a-c) . These models are extremely simplistic but show neatly how variation in different conversion rates can produce similar outcomes and model the quasiexponential increase in PrP Sc levels with time. In our experiment, sheep were infected with cattle BSE and the cross-species conversion of PrP C to PrP Sc may proceed more efficiently for L 141 protein than for F 141 , leading to higher initial levels of PrP Sc immediately after infection. In such a scenario, homologous-conversion reactions may proceed at equal rates, but the disease process in F 141 -carrying sheep will always trail that in L 141 sheep (Fig. 5a) . Alternatively, the incoming cattle inoculum may convert L 141 and F 141 proteins equally, but the subsequent homologous conversion of sheep proteins may proceed at different rates depending on codon 141 (Fig. 5b) . Both scenarios can account for the observed incubation times and similar levels of PrP Sc upon euthanasia, but it should be noted that these possibilities are not mutually exclusive. F 141 protein may convert less efficiently when catalysed by cattle PrP Sc from the incoming inoculum as well as by sheep PrP Sc during the homologous phase of disease (Fig. 5c ).
It is noteworthy that heterozygous sheep have the longest incubation periods and, presumably, the least efficient protein conversion. It has continually been hypothesized that this is a result of two distinct misfolding reactions occurring in vivo, one involving each protein, and that each proceeds at half the rate as in homozygous animals because only half the substrate exists. Such a scenario has been shown previously in studies of other polymorphisms in the ovine PRNP gene. Morel et al. used mass spectrometric methods to distinguish PrP Sc encoded by different PRNP allotypes and showed that the protein allele associated with susceptibility to scrapie was converted preferentially, resulting in its relative over-representation in pools of PrP Sc (Morel et al., 2007) . Likewise, Jacobs et al. used antibodies that specifically recognized different ovine PrP C variants to show that the PK-resistant material in ARR/VRQ sheep affected with scrapie was predominantly from the VRQ allele (Jacobs et al., 2011) . This effect is not specific to sheep; in humans heterozygote for a PRNP gene carrying a proline to leucine mutation at codon 102, associated with GerstmannStraussler-Scheinker disease, the PrP Sc that is deposited during disease appears predominantly to have emanated from the mutated allele (Tagliavini et al., 1994) . Almost two decades ago, it was noted that PrP C , which cannot readily be converted into PrP Sc , can have a dominant-negative effect on conversion of a more susceptible variant in cell culture. Although it is still not clear exactly how such an effect is mediated mechanistically, it seems likely that non-converting PrP C molecules can bind to PrP Sc aggregates without undergoing conversion themselves, thereby blocking binding sites for PrP C that is conversion competent. In any case, our data are consistent with more rapid formation of PrP Sc from the L141 allele in BSE-infected sheep, compared with the F141 allele, but we are currently unable to distinguish the two protein variants using in vitro tests so cannot confirm whether or not this is true.
Finally, the confirmation of similar levels of PrP Sc in the brains of sheep at clinical end-point from all three genotypes is compatible with equal conversion rates for the two proteins only if it is assumed that sheep carrying the F 141 alleles experience delayed transit of disease from gut to brain. Thus, it is possible that the route of infection plays a key role in determining the effect of codon 141 on TSE susceptibility.
METHODS
Ethical statement. All animal work was reviewed and approved by the ethical review panel at The Institute for Animal Health and The Roslin Institute and conducted under the authority of the Home Office Project Licences (references: 30/2282 and 60/4143, respectively).
In vivo experiments and data analysis. As part of our on-going BSE blood transfusion experiments, 39 Cheviot sheep (ARQ/ARQ genotype and derived from a scrapie-free flock) were orally infected with 5 g BSE brain homogenate (Houston et al., 2008; McCutcheon et al., 2011) . The inoculum was sourced from the Veterinary Laboratory Agency (VLA) (now known as Animal Health Veterinary Laboratory Agency) and was prepared from brainstem from approximately 100 cows confirmed as having BSE (inoculum reference SE1909/BBP-2). Five groups of eight sheep were infected typically at monthly intervals; the same batch was used to inoculate each sheep. Ten genotype-matched sheep were orally challenged with the same amount of uninfected (non-BSE exposed) bovine brain homogenate (from a single animal) at similar time intervals as the infected cohort. This inoculum was sourced from the VLA (inoculum reference PG1534/05). Following challenge, animals were monitored for clinical signs associated with BSE infection and culled at defined clinical endpoints. Non-BSE challenged controls were monitored in the same way and culled at pre-determined time points. For the purposes of data analysis, an experimental end date of November 2011 was assigned. At this point, three BSE-infected sheep were alive with survival periods greater than or equal to 1813 days. Incubation periods from sheep confirmed as having BSE and survival times for animals either alive at the end of the experiment or animals that were negative for BSE upon euthanasia were recorded.
Biochemistry. BSE infection was confirmed by analysis of brain and peripheral lymphoid tissues for the presence of disease-associated PrP using both Western blotting (McCutcheon et al., 2005) using the antibody BC6 (0.1 mg ml
21
) and/or immunohistochemistry using antibodies IH9/BG4 (1 mg ml 21 , BG4; TSE Resource Centre, The Roslin Institute) by using methods described previously . BC6 and IH9 were generated in The Roslin Institute against a truncated form of recombinant ovine PrP (ARQ genotype). Immunoblots were also probed with the anti-tubulin antibody alpha Ab-2 (0.01 mg ml 21 ; Neomarkers).
Densitometric analysis. Western blots of PK-treated and -untreated samples were carried out as described above using the anti-prion mouse monoclonal, BC6, and anti-tubulin antibody. Densitometric analysis was carried out as per manufacturer's instructions (Li-Cor).
Briefly, protein samples were transferred onto PVDF membrane (Immobilon-P; Millipore), blocked in Odyssey blocking buffer (LiCor) for 30 min, primary antibodies were diluted in 0.5 % Tween-20 in blocking buffer and were incubated overnight at 4 uC. Blots were washed with 0.1 % Tween-20 in PBS, before being incubated with 1 : 20 000 IRDye 800CW-conjugated goat (polyclonal) anti-mouse IgG (Li-Cor, 926-32210) in 0.01 % SDS, 0.5 % Tween-20 in PBS. After further washes, blots were visualized on an Odyssey Infrared Imager and densitometric analysis using the propriety software Image Studio 2. Five animals with confirmed BSE-infections were studied in three independent experiments with each sample repeated a minimum of two times for each genotype. A two-tail Student's t-test with unequal variance was carried out on normalized PrP C expression for all three genotypes and also for PK-treated samples. In some cases, and for confirmatory purposes, gels and subsequent densitometric analysis of selected samples were repeated a second time using five animals and PRNP genotyping. PRNP genotyping was performed on PCRamplified DNA fragments generated from genomic DNA that was extracted from tissue samples collected at post-mortem. A small piece of tissue (¡1 mg) was added to 400 ml of a 1 : 1 mixed buffer of PBS and TLB [1 % (w/v) SDS, 1 mM EDTA, pH 8.0, 10 mM Tris, pH 8.0 and 0.3 M sodium acetate]. To this, 200 ml PK (20 mg ml 21 ; Qiagen) was added, mixed and incubated at 37 uC for 1-5 h or overnight. Protein was removed by phenol/chloroform extraction. When tissue was totally dissolved, 400 ml equilibrated phenol (pH 8.0) and 400 ml chloroform were added, mixed and spun at 14 000 r.p.m. (20 800 rcf) for 5 min. The upper phase was transferred to a new tube and the extraction repeated. The upper phase was then precipitated following a standard ethanol DNA precipitation protocol. The DNA was dissolved in water or TE buffer (pH 7.5) at a suitable concentration, usually in 100 ml.
PCR amplification was performed using Sigma JumpStart REDTaq DNA polymerase and buffers, 200 mM (each) dNTPs (Roche) and 0.4 mM of each oligonucleotide primer Sigma-Aldrich. Oligonucleotides for the PCR were PS-141d (59-GGAATGTGAAGAACATTTAT-GACCTAGAAT-39) and PS+109u (59-CAAGAGAGAAGCAAGA-AATGAGACA-39).
PCR conditions were as follows: one incubation for 3 min at 95 uC followed by 40 cycles of 30 s at 95 uC, 30 s at 61 uC and 1 min at 72 uC. A final elongation step of 10 min at 72 uC concluded PCR. The PCR products were purified by an addition of 15 ml activated charcoal suspension (0.8 g of activated charcoal, particle size 100-400 suspended in 50 ml of dH 2 O) and incubation at room temperature for at least 10 min. After centrifugation at 12 000 g for 5 min to pellet the charcoal, 1-3 ml aliquots of the supernatant were taken to sequence the PCR fragments directly in the upstream direction with oligonucleotide PS+50u (59-CCCCCAACCTGGCAAAGATTAAGA-39) using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). Sequencing reactions were purified by ethanol/EDTA precipitation as per the manufacturer's protocol and then run on an Applied Biosystems 3130 Genetic Analyzer (Applied Biosystems). Sequences were analysed manually.
